News

PulmOne will now be offering the NIOX VERO® fractional exhaled nitric oxide (FeNO) airway inflammation measurement system as an add-on to the MiniBox+. The combined system will be offered to both companies' current users as well as to new customers. See Press Release....

PulmOne has just launched sales to the Japanese market, under the leadership of Yan Zlicha and Koshi Tokuda. Based in Tokyo, Mr. Zlicha has successfully introduced a number of Israeli medical technologies to the Japanese market, including both imaging and diagnostic devices. Mr. Tokuda has...

We welcome Harold Smeets on board to lead our sales and marketing operations in Europe, the Middle East, and Africa. Harold brings with him over 30 years’ experience in the field of cardiorespiratory diagnostics, including a number of senior leadership roles in international sales, upstream...

PulmOne is participating as an exhibitor at three major industry meetings between October and December this year.  We will be conducting live demo’s of the MiniBox at our booth at CHEST 2018 in San Antonio, ACAAI 2018 in Seattle, and AARC 2018 in Las Vegas. ...

Scott Yokobosky joins the PulmOne team with 20 years' successful experience in several sales leadership positions in both pharmaceutical and medical device companies. We welcome him aboard as he leads our national sales team in North America....

PulmOne will be displaying the MiniBox next week at the Joint Congress of the American Academy of Allergy, Asthma, and Immunology and the World Allergy Organization in Orlando. As always, we will be demo-ing the MiniBox at our booth, and providing detailed information about our...

With the MiniBox+, hospitals and clinics can now perform complete Pulmonary Function Testing AND transfer the results to their EHR management system, keeping local and central systems synchronized. The MiniBox+ EHR connectivity module is HL7 compliant, easily configurable, and integrates with all major EHR systems....

The MiniBox+ now supports data entry of the 6-Minute Walk Test (6MWT) and allows for reporting results along with patient pulmonary function data. The 6MWT is a simple and objective measurement of functional capacity commonly used to assess patients with cardiovascular and/or respiratory diseases....